References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Gerlachetal(1992)ThemolecularpharmacologyofL-deprenyl.Eur.J.Pharmacol.22697PMID:1639115
Kasedaetal(1999)Effectofselegelineondopamineconcentrationinthestriatumofaprimate.BrainRes.81544PMID:9974121
Kotakeetal(1998)Deprenyldecreasesanendogenousparkinsonism-inducingcompound,1-benzyl-1,2,3,4-tetrahydroisoquinolineinmice:invivoandinvitrostudies.BrainRes.787341PMID:9518683
Mercurietal(1998)Modificationoflevodoparesponsesbydeprenyl(selegiline):anelectrophysiologicalandbehaviouralstudyintheratrelevanttoParkinson'sdisease.Ann.Neurol.43613PMID:9585355
MerckIndex128569PMID:
Keywords:(R)-(-)-Deprenylhydrochloride,supplier,MAO-B,inhibitors,inhibits,Monoamine,Oxygenases,Oxidases,parkinson's,parkinsons,Selegiline,Monoamine,Oxidase,Adrenergic,Related,Compounds,Dopaminergic-Related,5-HT-Related,5-HT3,Receptors,Monoamine,Oxidase,TocrisBioscience